Joining industry leaders and innovators, Michael Gaba spoke at the 44th annual J.P. Morgan Healthcare Conference, in San Francisco. He and fellow panelists identified the most impactful recent and emerging regulatory policy changes at the FDA shaping the Life Sciences industry and discussed the operational implications of these changes with a specific focus on early and growth-stage companies.